RAB5B and breast cancer: miR-130a-3p has been shown to inhibit migration and invasion through RAB5B regulation, and is downregulated in circulating EVs in BC patients, whilst overexpression in BC stem cells (BCSCs) inhibits migration and proliferation through G0/G1 arrest.